论文信息 - Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models - 字舞流文

Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models

U. Hoch | S. Kashimoto | J. Silverman | Y. Furutani | Yuji Sato | J. Lynch | F. Kajikawa | Fumie Kajikawa